Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 13/20 | 0.69 |
| ▸ | MMP9 | P14780 | 12/20 | 0.69 |
| ▸ | MMP2 | P08253 | 11/20 | 0.69 |
| ▸ | MMP12 | P39900 | 10/20 | 0.69 |
| ▸ | MMP14 | P50281 | 10/20 | 0.69 |
| ▸ | MMP15 | P51511 | 10/20 | 0.69 |
| ▸ | MMP16 | P51512 | 10/20 | 0.69 |
| ▸ | MMP26 | Q9NRE1 | 10/20 | 0.69 |
| ▸ | MMP7 | P09237 | 8/20 | 0.55 |
| ▸ | MMP3 | P08254 | 5/20 | 0.52 |
| ▸ | MMP8 | P22894 | 4/20 | 0.52 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1020024 | 0.91 | MMP1 (0.66) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL5438666 | 0.89 | MMP1 (0.63) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL5164049 | 0.89 | MMP1 (0.52) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL1024080 | 0.84 | MMP1 (0.53) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL1021277 | 0.84 | MMP1 (0.53) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL1021877 | 0.83 | MMP1 (0.56) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL3534852 | 0.83 | MMP1 (0.77) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL1021032 | 0.81 | MMP1 (0.49) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL5160366 | 0.81 | MMP1 (0.51) | MMP1MMP9MMP2MMP12MMP14 | |
| SCHEMBL1021428 | 0.81 | MMP1 (0.49) | MMP1MMP9MMP2MMP12MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1763516-A2 | SUBSTITUTED TETRAHYDROISOCHINOLINES USED IN THE FORM OF MMP INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRAGS | Sanofi-Aventis Deutschland GmbH (DE) | 2007-03-21 | — | — | EP | disclosed |
| WO-2006002763-A2 | SUBSTITUTED TETRAHYDROISOCHINOLINES USED IN THE FORM OF MMP INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRAGS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-01-12 | — | — | WO | disclosed |